RxDoctor Payments Data

Elise Mecham, MD

Plastic Surgery · American Fork, UTNPI 1336402569

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.7%), food and beverage and other — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by AbbVie at 33.0% of the total. Reporting peaked in 2024 at $6,724 and has fallen 54.8% since, to $3,041 in 2025.

$16,980in general payments, 2019–2025

Across 224 payments — averaging $75.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Axogen$3K
  • Mentor Worldwide LLC$2K
  • Medical Device Business Services, Inc.$1K
  • Davol Inc.$1K
  • Integra Lifesciences Corporation$1K
  • plus $2K from 27 others

What the payments were for

  • Travel & lodging$8,61651%
  • Food & beverage$7,38744%
  • Other$9776%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,980 in reported general payments places this provider in the 85th percentile of 71 plastic surgery providers in Utah.

See all plastic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$28,839
Medicare patients
23
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib15$348
Cephalexin20$219
Ondansetron OdtOndansetron15$107
Gabapentin16$69
Oxycodone Hcl15$33

Paid to pharmacies, not to this prescriber.

Other plastic surgery in American Fork

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →